» Articles » PMID: 33197366

Hepatitis C Antibody Screening Among Baby Boomers by a Community-Based Health Insurance Company

Overview
Publisher Mary Ann Liebert
Date 2020 Nov 16
PMID 33197366
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Infection with the hepatitis C virus (HCV) is the most commonly reported bloodborne infection in the United States. Individuals born between 1945-1965, the baby boomers, account for approximately 75% of all chronic HCV infections in the United States. The purpose of this study was to determine if a 6-week intervention, including outreach, education, and incentive, by a community-based health insurance company could improve uptake of HCV antibody screening among the 1945-1965 birth cohort. Individuals were eligible to participate in this campaign if they were born on or after January 1, 1945 and on or before December 31, 1965, had health insurance with Sendero Health Plans during the intervention period, and had no evidence of having received an HCV antibody test prior to the campaign start date. The 6-week campaign period was from November 14, 2018 through December 31, 2018. A gift card incentive was provided if HCV screening was completed on or before December 31, 2018. A total of 5287 individuals were eligible to participate in the campaign. Members who were baby boomers were 3.36 times more likely to receive HCV antibody screening during the intervention period in 2018 than during a similar period in 2017 (prevalence ratio = 3.36;  < 0.0001; 95% confidence interval: 2.71, 4.16). Health officials have established the identification, treatment, and elimination of HCV as a national policy objective. Using an outreach, education, and incentive approach, Sendero Health Plans improved uptake of HCV antibody screening among the high-risk baby boomer population.

Citing Articles

Evaluation of a Project Integrating Financial Incentives into a Hepatitis C Testing and Treatment Model of Care at a Sexual Health Service in Cairns, Australia, 2020-2021.

Dawe J, Gorton C, Lewis R, Richmond J, Wilkinson A, Pedrana A Viruses. 2024; 16(5).

PMID: 38793681 PMC: 11125761. DOI: 10.3390/v16050800.


Assessing Physicians' Recommendations for Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Testing Among Minority Populations in Greater Philadelphia and New York City.

Begum T, Patil V, Zhu L, Yeh M, Gonzalez E, Fraser M J Community Health. 2024; 49(4):588-597.

PMID: 38286964 DOI: 10.1007/s10900-023-01316-3.


Hepatitis C Virus Screening among Baby Boomers: The Positive Benefits of Health Education and Outreach during the COVID-19 Pandemic.

Lopez Bray C, Taylor R, Tamez N, Durkalski W, Litaker J Healthcare (Basel). 2023; 11(3).

PMID: 36766877 PMC: 9914406. DOI: 10.3390/healthcare11030302.

References
1.
Oliver A . Can financial incentives improve health equity?. BMJ. 2009; 339:b3847. DOI: 10.1136/bmj.b3847. View

2.
Coward S, Leggett L, Kaplan G, Clement F . Cost-effectiveness of screening for hepatitis C virus: a systematic review of economic evaluations. BMJ Open. 2016; 6(9):e011821. PMC: 5020747. DOI: 10.1136/bmjopen-2016-011821. View

3.
Litaker J, Tamez N, Palma C, Durkalski W, Taylor R . A Randomized Controlled Trial to Increase Diabetic Retinopathy Screening by a Community-Based Health Insurance Plan in Central Texas - 2017. Ophthalmic Epidemiol. 2020; 27(5):376-383. DOI: 10.1080/09286586.2020.1746360. View

4.
Falade-Nwulia O, Suarez-Cuervo C, Nelson D, Fried M, Segal J, Sulkowski M . Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review. Ann Intern Med. 2017; 166(9):637-648. PMC: 5486987. DOI: 10.7326/M16-2575. View

5.
Coyle C, Kwakwa H, Viner K . Integrating Routine HCV Testing in Primary Care: Lessons Learned from Five Federally Qualified Health Centers in Philadelphia, Pennsylvania, 2012-2014. Public Health Rep. 2016; 131 Suppl 2:65-73. PMC: 4853331. DOI: 10.1177/00333549161310S211. View